Mouse gut metagenome
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA306507 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Quercetin improves gut dysbiosis in antibiotics-treated mice
| PRJNA607614 | ENA
Project description:DNA methylation profile of mouse sperm from conventionally-raised mice and gut dysbiosis experienced mice were characterized using whole-genome bisulfite sequencing. Genome-wide DNA methylation changes between control and dysbiotic male�s sperm were highly comparable, with no change in DNAme globally or at genomic features, only 21 differentially methylated regions (DMR) were identified, which did not overlap known regulatory elements. Epididymal sperm samples were harvested from 11 weeks old inbred male mice that were experiencing gut microbiota dysbiosis for 6-week (antibiotics treated, n=5), or drink sterilized water (control, n=5).
2023-11-13 | E-MTAB-10033 | biostudies-arrayexpress
Project description:Aged gut microbiota lead to gut dysbiosis with a potential to induce obesity in mice
| PRJDB9743 | ENA
Project description:Effect of pectic oligosaccharide based synbiotic formulation on dysbiosis mice model gut microbial diversity modulation.
| PRJNA1151701 | ENA
Project description:The Circadian Clock Mutation Promotes Intestinal Dysbiosis
| PRJNA1086924 | ENA
Project description:Gut bacterial microbiome of mice treated with anti-fungal Amphotericin B Targeted loci
| PRJNA317649 | ENA
Project description:Morphine and its pharmacological derivatives are the most prescribed analgesics for moderate to severe pain management. However, chronic use of morphine reduces pathogen clearance and induces bacterial translocation across the gut barrier. The enteric microbiome has been shown to play a critical role in the preservation of the mucosal barrier function and metabolic homeostasis. Here, we show for the first time, using bacterial 16s rDNA sequencing, that chronic morphine treatment significantly alters the gut microbial composition and induces preferential expansion of the gram-positive pathogenic and reduction of bile-deconjugating bacterial strains. A significant reduction in both primary and secondary bile acid levels was seen in the gut, but not in the liver with morphine treatment. Morphine induced microbial dysbiosis and gut barrier disruption was rescued by transplanting placebo-treated microbiota into morphine-treated animals, indicating that microbiome modulation could be exploited as a therapeutic strategy for patients using morphine for pain management. In this study, we establish a link between the two phenomena, namely gut barrier compromise and dysregulated bile acid metabolism. We show for the first time that morphine fosters significant gut microbial dysbiosis and disrupts cholesterol/bile acid metabolism. Changes in the gut microbial composition is strongly correlated to disruption in host inflammatory homeostasis13,14 and in many diseases (e.g. cancer/HIV infection), persistent inflammation is known to aid and promote the progression of the primary morbidity. We show here that chronic morphine, gut microbial dysbiosis, disruption of cholesterol/bile acid metabolism and gut inflammation; have a linear correlation. This opens up the prospect of devising minimally invasive adjunct treatment strategies involving microbiome and bile acid modulation and thus bringing down morphine-mediated inflammation in the host.
2016-06-01 | E-MTAB-3722 | biostudies-arrayexpress
Project description:The Circadian Clock Mutation Promotes Intestinal Dysbiosis (Revised)
| PRJNA1088096 | ENA
Project description:Campylobacter jejuni Colonization is Associated with a Dysbiosis in the Cecal Microbiota of Mice in the Absence of Prominent Inflammation
| PRJNA211485 | ENA